The store will not work correctly when cookies are disabled.
4-[3-(4-Methylphenyl)-4-ethyl-5-oxo-2-thioxoimidazolidin-1-yl]-2-trifluoromethylbenzonitrile
ID: ALA1086121
PubChem CID: 46889873
Max Phase: Preclinical
Molecular Formula: C20H16F3N3OS
Molecular Weight: 403.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCC1C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C)cc1
Standard InChI: InChI=1S/C20H16F3N3OS/c1-3-17-18(27)26(19(28)25(17)14-7-4-12(2)5-8-14)15-9-6-13(11-24)16(10-15)20(21,22)23/h4-10,17H,3H2,1-2H3
Standard InChI Key: XAULKLGBXQJPRT-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
-2.8348 -2.9166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8359 -3.7440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1211 -4.1569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4047 -3.7435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4075 -2.9130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1229 -2.5039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5505 -2.4985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2650 -2.0862 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.5507 -4.1559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2649 -3.7429 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-3.5514 -4.9809 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-3.7636 -3.3589 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-0.7370 -4.2205 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7297 -5.0455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0572 -5.2935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5362 -4.6218 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0453 -3.9587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3928 -5.5363 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.2933 -3.1719 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.3601 -4.6128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7800 -5.3252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6050 -5.3167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0111 -4.5966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5861 -3.8836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7625 -3.8955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8361 -4.5867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3190 -6.0758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2276 -6.6938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 4 2 0
7 8 3 0
1 7 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 13 1 0
4 13 1 0
14 18 2 0
2 9 1 0
17 19 2 0
16 20 1 0
4 5 1 0
9 10 1 0
20 21 2 0
2 3 1 0
21 22 1 0
9 11 1 0
22 23 2 0
5 6 2 0
23 24 1 0
9 12 1 0
24 25 2 0
25 20 1 0
13 14 1 0
23 26 1 0
6 1 1 0
15 27 1 0
1 2 2 0
27 28 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 403.43 | Molecular Weight (Monoisotopic): 403.0966 | AlogP: 4.80 | #Rotatable Bonds: 3 |
Polar Surface Area: 47.34 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.99 | CX Basic pKa: ┄ | CX LogP: 5.54 | CX LogD: 5.54 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.69 | Np Likeness Score: -1.43 |
References
1. Jung ME, Ouk S, Yoo D, Sawyers CL, Chen C, Tran C, Wongvipat J.. (2010) Structure-activity relationship for thiohydantoin androgen receptor antagonists for castration-resistant prostate cancer (CRPC)., 53 (7): [PMID:20218717] [10.1021/jm901488g] |